NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVB and the CUSIP is 63937X202. A total of 40 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q3 2020. The put-call ratio across all filers is 0.51 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $7 | +40.0% | 28,416 | -0.4% | 0.00% | – |
| Q4 2022 | $5 | -99.9% | 28,516 | +50.0% | 0.00% | – |
| Q3 2022 | $4,000 | -81.0% | 19,016 | -35.8% | 0.00% | – |
| Q2 2022 | $21,000 | +600.0% | 29,616 | +597.0% | 0.00% | – |
| Q1 2022 | $3,000 | -83.3% | 4,249 | -77.2% | 0.00% | – |
| Q4 2021 | $18,000 | -21.7% | 18,668 | +41.6% | 0.00% | – |
| Q3 2021 | $23,000 | -4.2% | 13,179 | 0.0% | 0.00% | – |
| Q2 2021 | $24,000 | -4.0% | 13,179 | +12.1% | 0.00% | – |
| Q4 2020 | $25,000 | -56.1% | 11,755 | -44.6% | 0.00% | – |
| Q3 2020 | $57,000 | -21.9% | 21,212 | +13.2% | 0.00% | – |
| Q2 2020 | $73,000 | +7200.0% | 18,736 | +836.8% | 0.00% | – |
| Q3 2019 | $1,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FNY Investment Advisers, LLC | 199,220 | $151,000 | 0.12% |
| Allred Capital Management, LLC | 20,528 | $15,000 | 0.01% |
| PATHSTONE FAMILY OFFICE, LLC | 10,050 | $8,000 | 0.00% |
| LifePlan Financial Group, Inc | 1,440 | $1,000 | 0.00% |
| VICTORY CAPITAL MANAGEMENT INC | 4,806 | $4,000 | 0.00% |
| UBS Group AG | 105 | $0 | 0.00% |
| Sowell Financial Services LLC | 2,819 | $2,000 | 0.00% |
| IFP Advisors, Inc | 50 | $0 | 0.00% |
| OSAIC HOLDINGS, INC. | 6 | $0 | 0.00% |
| Jacobi Capital Management LLC | 1,000 | $1,000 | 0.00% |